Kaketsuken's operations suspended over irregular blood products

Seiji Miyamoto (L), head of Japanese blood products and vaccine maker Kaketsuken, receives from health ministry official Hideaki Nakagaki a document ordering the company to suspend business for 110 days, the longest penalty ever handed down under Japan's pharmaceutical law, on Jan. 8, 2016. Kaketsuken was found to have been adding unauthorized ingredients to its products and falsifying records. (Kyodo) ==Kyodo

• Product Code
• ILEA000082046

• Registered date
• 2016/1/08 17:20:22

• Credit
• Kyodo / Kyodo News Images

• Media source

• Media size
• 3696 × 2364 pixel

• Resolution
• 240 dpi

• Deployment size
• 898.87(KB)*

• Special instruction

*File size when opened in Photoshop, etc.